Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Shares of Eli Lilly & Co. LLY advanced 1.11% to $915.04 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 and ...

SEATTLE — Ex-employees of formerly Seattle-based Zulily have filed a class-action lawsuit against the company, alleging that many employees were not given proper notice or pay after mass layoffs in ...

according to the company’s website. Most U.S. patients are covered by health insurance and would likely pay less for the drugs. Novo and rival Eli Lilly, which makes the weight loss drug Zepbound, ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself “at my ideal ...

For years, the healthcare industry has been a cornerstone of the economy, offering resilience in both stable and uncertain ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and older ...

In a sweeping new lawsuit, over 900 people are claiming that Ozempic and other GLP-1 drugs caused them long-term ...